Study of tuberculosis and AIDS stigma as barriers to tuberculosis treatment adherence using validated stigma scales
BACKGROUND: Adherence to tuberculosis (TB) treatment is important for TB control. The effect of stigma on adherence has not been well quantified. OBJECTIVE: To identify the effects of TB and acquired immune-deficiency syndrome (AIDS) stigma on missed doses during TB treatment. DESIGN: Validated TB a...
Gespeichert in:
| Veröffentlicht in: | The international journal of tuberculosis and lung disease 2011-11, Vol.15 (11), p.1540-1546 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1546 |
|---|---|
| container_issue | 11 |
| container_start_page | 1540 |
| container_title | The international journal of tuberculosis and lung disease |
| container_volume | 15 |
| creator | Kipp Pungrassami Stewart Chongsuvivatwong Strauss Van Rie, A. |
| description | BACKGROUND: Adherence to tuberculosis (TB) treatment is important for TB control. The effect of stigma on adherence has not been well quantified. OBJECTIVE: To identify the effects of TB and acquired immune-deficiency syndrome (AIDS) stigma on missed doses during TB treatment. DESIGN:
Validated TB and AIDS stigma scales assessing perceived and experienced/felt stigma were administered in a prospective cohort of 459 TB patients at TB treatment initiation and after 2 months. Repeated measures and multivariable models estimated the effects of stigma on the rate of missed doses.
RESULTS: Fifty-six per cent of patients missed no doses, and associations between stigma and missed doses were minimal. Heterogeneity of effects was observed, how- ever, with higher experienced and felt TB stigma increasing missed doses among women (adjusted RR 1.22, 95%CI 1.10-1.34)
and human immunodeficiency virus (HIV) co-infected patients (aRR 1.39, 95%CI 1.13-1.72). Experienced and felt AIDS stigma also increased missed doses among HIV co-infected patients (aRR 1.43, 95%CI 1.31-1.56). CONCLUSION: Stigma has a minimal effect in this population with good
adherence. Among women and HIV co-infected patients, however, experienced and felt stigma, and not perceived stigma, increased the rate of missed doses. Further research is needed to determine if stigma or coping interventions among these subgroups would improve adherence. |
| doi_str_mv | 10.5588/ijtld.10.0273 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_24756119</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ingid>iuatld/ijtld/2011/00000015/00000011/art00023</ingid><sourcerecordid>911163342</sourcerecordid><originalsourceid>FETCH-LOGICAL-c529t-aafceff9b18f07dc1bb074f375ae4759114436cb911b1b41e6cfca03e5f3bfe23</originalsourceid><addsrcrecordid>eNqNkk1v1DAQhiMEoh9w5Ip8QZxSPE4cJ8eqhVKpEhKFszV2xotX-Si2U6n99TjdXRAHJHzxO9bjd-yZKYo3wM-kbNsPfpuG_ixHXKjqWXEMLchSdYI_zzqflZWC7qg4iXHLuQAA9bI4EoLzVil-XMTbtPQPbHYsLYaCXYY5-shw6tn59eUti8lvRmQYmcEQPIXI0vw3mwJhGmlKDPsfFGiyxJbopw27x8H3mKg_2ESLA8VXxQuHQ6TX-_20-P7p47eLz-XNl6vri_Ob0krRpRLRWXKuM9A6rnoLxnBVu0pJpFrJDqCuq8aaLAyYGqixziKvSLrKOBLVafF-53sX5p8LxaRHHy0NA040L1Hni9BUVf0fJOeNkFyuZLkjbZhjDOT0XfAjhgcNXK8N0U8NWaO1IZl_u3dezEj9b_rQgQy82wO4VscFnKyPf7j80wagy9zljsuFzbVGvZ2XMOXyab_gmnGXV3AAzZ8WyIMAjSFlIdb3fP2XjT04rWOzTo2-BznlyyLPDW-F1FBLoXtyuAxJJwx686hjNv0F5h7HqA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>900625052</pqid></control><display><type>article</type><title>Study of tuberculosis and AIDS stigma as barriers to tuberculosis treatment adherence using validated stigma scales</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Kipp ; Pungrassami ; Stewart ; Chongsuvivatwong ; Strauss ; Van Rie, A.</creator><creatorcontrib>Kipp ; Pungrassami ; Stewart ; Chongsuvivatwong ; Strauss ; Van Rie, A.</creatorcontrib><description>BACKGROUND: Adherence to tuberculosis (TB) treatment is important for TB control. The effect of stigma on adherence has not been well quantified. OBJECTIVE: To identify the effects of TB and acquired immune-deficiency syndrome (AIDS) stigma on missed doses during TB treatment. DESIGN:
Validated TB and AIDS stigma scales assessing perceived and experienced/felt stigma were administered in a prospective cohort of 459 TB patients at TB treatment initiation and after 2 months. Repeated measures and multivariable models estimated the effects of stigma on the rate of missed doses.
RESULTS: Fifty-six per cent of patients missed no doses, and associations between stigma and missed doses were minimal. Heterogeneity of effects was observed, how- ever, with higher experienced and felt TB stigma increasing missed doses among women (adjusted RR 1.22, 95%CI 1.10-1.34)
and human immunodeficiency virus (HIV) co-infected patients (aRR 1.39, 95%CI 1.13-1.72). Experienced and felt AIDS stigma also increased missed doses among HIV co-infected patients (aRR 1.43, 95%CI 1.31-1.56). CONCLUSION: Stigma has a minimal effect in this population with good
adherence. Among women and HIV co-infected patients, however, experienced and felt stigma, and not perceived stigma, increased the rate of missed doses. Further research is needed to determine if stigma or coping interventions among these subgroups would improve adherence.</description><identifier>ISSN: 1027-3719</identifier><identifier>EISSN: 1815-7920</identifier><identifier>DOI: 10.5588/ijtld.10.0273</identifier><identifier>PMID: 22008770</identifier><language>eng</language><publisher>Paris: International Union Against Tuberculosis and Lung Disease</publisher><subject>Adaptation, Psychological ; Adherence ; Adolescent ; Adult ; Aged ; Anti-HIV Agents - therapeutic use ; Antitubercular Agents - therapeutic use ; Bacterial diseases ; Biological and medical sciences ; Coinfection - drug therapy ; Coinfection - epidemiology ; Coinfection - psychology ; Female ; Health Knowledge, Attitudes, Practice ; HIV Infections - drug therapy ; HIV Infections - epidemiology ; HIV Infections - psychology ; Human bacterial diseases ; Human immunodeficiency virus ; Human viral diseases ; Humans ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunopathology ; Infectious diseases ; Male ; Medical sciences ; Medication Adherence - psychology ; Middle Aged ; Mycobacterium ; Perception ; Pneumology ; Prognosis ; Prospective Studies ; Public Opinion ; Regression Analysis ; Reproducibility of Results ; Respiratory system : syndromes and miscellaneous diseases ; Risk Assessment ; Risk Factors ; Social Stigma ; Stereotyping ; Stigma ; Thailand - epidemiology ; Tuberculosis ; Tuberculosis - drug therapy ; Tuberculosis - epidemiology ; Tuberculosis - psychology ; Tuberculosis and atypical mycobacterial infections ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids ; Young Adult</subject><ispartof>The international journal of tuberculosis and lung disease, 2011-11, Vol.15 (11), p.1540-1546</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c529t-aafceff9b18f07dc1bb074f375ae4759114436cb911b1b41e6cfca03e5f3bfe23</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24756119$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22008770$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kipp</creatorcontrib><creatorcontrib>Pungrassami</creatorcontrib><creatorcontrib>Stewart</creatorcontrib><creatorcontrib>Chongsuvivatwong</creatorcontrib><creatorcontrib>Strauss</creatorcontrib><creatorcontrib>Van Rie, A.</creatorcontrib><title>Study of tuberculosis and AIDS stigma as barriers to tuberculosis treatment adherence using validated stigma scales</title><title>The international journal of tuberculosis and lung disease</title><addtitle>Int J Tuberc Lung Dis</addtitle><addtitle>Int J Tuberc Lung Dis</addtitle><description>BACKGROUND: Adherence to tuberculosis (TB) treatment is important for TB control. The effect of stigma on adherence has not been well quantified. OBJECTIVE: To identify the effects of TB and acquired immune-deficiency syndrome (AIDS) stigma on missed doses during TB treatment. DESIGN:
Validated TB and AIDS stigma scales assessing perceived and experienced/felt stigma were administered in a prospective cohort of 459 TB patients at TB treatment initiation and after 2 months. Repeated measures and multivariable models estimated the effects of stigma on the rate of missed doses.
RESULTS: Fifty-six per cent of patients missed no doses, and associations between stigma and missed doses were minimal. Heterogeneity of effects was observed, how- ever, with higher experienced and felt TB stigma increasing missed doses among women (adjusted RR 1.22, 95%CI 1.10-1.34)
and human immunodeficiency virus (HIV) co-infected patients (aRR 1.39, 95%CI 1.13-1.72). Experienced and felt AIDS stigma also increased missed doses among HIV co-infected patients (aRR 1.43, 95%CI 1.31-1.56). CONCLUSION: Stigma has a minimal effect in this population with good
adherence. Among women and HIV co-infected patients, however, experienced and felt stigma, and not perceived stigma, increased the rate of missed doses. Further research is needed to determine if stigma or coping interventions among these subgroups would improve adherence.</description><subject>Adaptation, Psychological</subject><subject>Adherence</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Antitubercular Agents - therapeutic use</subject><subject>Bacterial diseases</subject><subject>Biological and medical sciences</subject><subject>Coinfection - drug therapy</subject><subject>Coinfection - epidemiology</subject><subject>Coinfection - psychology</subject><subject>Female</subject><subject>Health Knowledge, Attitudes, Practice</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - epidemiology</subject><subject>HIV Infections - psychology</subject><subject>Human bacterial diseases</subject><subject>Human immunodeficiency virus</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Medication Adherence - psychology</subject><subject>Middle Aged</subject><subject>Mycobacterium</subject><subject>Perception</subject><subject>Pneumology</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>Public Opinion</subject><subject>Regression Analysis</subject><subject>Reproducibility of Results</subject><subject>Respiratory system : syndromes and miscellaneous diseases</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Social Stigma</subject><subject>Stereotyping</subject><subject>Stigma</subject><subject>Thailand - epidemiology</subject><subject>Tuberculosis</subject><subject>Tuberculosis - drug therapy</subject><subject>Tuberculosis - epidemiology</subject><subject>Tuberculosis - psychology</subject><subject>Tuberculosis and atypical mycobacterial infections</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><subject>Young Adult</subject><issn>1027-3719</issn><issn>1815-7920</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkk1v1DAQhiMEoh9w5Ip8QZxSPE4cJ8eqhVKpEhKFszV2xotX-Si2U6n99TjdXRAHJHzxO9bjd-yZKYo3wM-kbNsPfpuG_ixHXKjqWXEMLchSdYI_zzqflZWC7qg4iXHLuQAA9bI4EoLzVil-XMTbtPQPbHYsLYaCXYY5-shw6tn59eUti8lvRmQYmcEQPIXI0vw3mwJhGmlKDPsfFGiyxJbopw27x8H3mKg_2ESLA8VXxQuHQ6TX-_20-P7p47eLz-XNl6vri_Ob0krRpRLRWXKuM9A6rnoLxnBVu0pJpFrJDqCuq8aaLAyYGqixziKvSLrKOBLVafF-53sX5p8LxaRHHy0NA040L1Hni9BUVf0fJOeNkFyuZLkjbZhjDOT0XfAjhgcNXK8N0U8NWaO1IZl_u3dezEj9b_rQgQy82wO4VscFnKyPf7j80wagy9zljsuFzbVGvZ2XMOXyab_gmnGXV3AAzZ8WyIMAjSFlIdb3fP2XjT04rWOzTo2-BznlyyLPDW-F1FBLoXtyuAxJJwx686hjNv0F5h7HqA</recordid><startdate>20111101</startdate><enddate>20111101</enddate><creator>Kipp</creator><creator>Pungrassami</creator><creator>Stewart</creator><creator>Chongsuvivatwong</creator><creator>Strauss</creator><creator>Van Rie, A.</creator><general>International Union Against Tuberculosis and Lung Disease</general><general>International Union against Tuberculosis and Lung Disease</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QL</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope></search><sort><creationdate>20111101</creationdate><title>Study of tuberculosis and AIDS stigma as barriers to tuberculosis treatment adherence using validated stigma scales</title><author>Kipp ; Pungrassami ; Stewart ; Chongsuvivatwong ; Strauss ; Van Rie, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c529t-aafceff9b18f07dc1bb074f375ae4759114436cb911b1b41e6cfca03e5f3bfe23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adaptation, Psychological</topic><topic>Adherence</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Antitubercular Agents - therapeutic use</topic><topic>Bacterial diseases</topic><topic>Biological and medical sciences</topic><topic>Coinfection - drug therapy</topic><topic>Coinfection - epidemiology</topic><topic>Coinfection - psychology</topic><topic>Female</topic><topic>Health Knowledge, Attitudes, Practice</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - epidemiology</topic><topic>HIV Infections - psychology</topic><topic>Human bacterial diseases</topic><topic>Human immunodeficiency virus</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Medication Adherence - psychology</topic><topic>Middle Aged</topic><topic>Mycobacterium</topic><topic>Perception</topic><topic>Pneumology</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>Public Opinion</topic><topic>Regression Analysis</topic><topic>Reproducibility of Results</topic><topic>Respiratory system : syndromes and miscellaneous diseases</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Social Stigma</topic><topic>Stereotyping</topic><topic>Stigma</topic><topic>Thailand - epidemiology</topic><topic>Tuberculosis</topic><topic>Tuberculosis - drug therapy</topic><topic>Tuberculosis - epidemiology</topic><topic>Tuberculosis - psychology</topic><topic>Tuberculosis and atypical mycobacterial infections</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kipp</creatorcontrib><creatorcontrib>Pungrassami</creatorcontrib><creatorcontrib>Stewart</creatorcontrib><creatorcontrib>Chongsuvivatwong</creatorcontrib><creatorcontrib>Strauss</creatorcontrib><creatorcontrib>Van Rie, A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>The international journal of tuberculosis and lung disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kipp</au><au>Pungrassami</au><au>Stewart</au><au>Chongsuvivatwong</au><au>Strauss</au><au>Van Rie, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Study of tuberculosis and AIDS stigma as barriers to tuberculosis treatment adherence using validated stigma scales</atitle><jtitle>The international journal of tuberculosis and lung disease</jtitle><stitle>Int J Tuberc Lung Dis</stitle><addtitle>Int J Tuberc Lung Dis</addtitle><date>2011-11-01</date><risdate>2011</risdate><volume>15</volume><issue>11</issue><spage>1540</spage><epage>1546</epage><pages>1540-1546</pages><issn>1027-3719</issn><eissn>1815-7920</eissn><abstract>BACKGROUND: Adherence to tuberculosis (TB) treatment is important for TB control. The effect of stigma on adherence has not been well quantified. OBJECTIVE: To identify the effects of TB and acquired immune-deficiency syndrome (AIDS) stigma on missed doses during TB treatment. DESIGN:
Validated TB and AIDS stigma scales assessing perceived and experienced/felt stigma were administered in a prospective cohort of 459 TB patients at TB treatment initiation and after 2 months. Repeated measures and multivariable models estimated the effects of stigma on the rate of missed doses.
RESULTS: Fifty-six per cent of patients missed no doses, and associations between stigma and missed doses were minimal. Heterogeneity of effects was observed, how- ever, with higher experienced and felt TB stigma increasing missed doses among women (adjusted RR 1.22, 95%CI 1.10-1.34)
and human immunodeficiency virus (HIV) co-infected patients (aRR 1.39, 95%CI 1.13-1.72). Experienced and felt AIDS stigma also increased missed doses among HIV co-infected patients (aRR 1.43, 95%CI 1.31-1.56). CONCLUSION: Stigma has a minimal effect in this population with good
adherence. Among women and HIV co-infected patients, however, experienced and felt stigma, and not perceived stigma, increased the rate of missed doses. Further research is needed to determine if stigma or coping interventions among these subgroups would improve adherence.</abstract><cop>Paris</cop><pub>International Union Against Tuberculosis and Lung Disease</pub><pmid>22008770</pmid><doi>10.5588/ijtld.10.0273</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1027-3719 |
| ispartof | The international journal of tuberculosis and lung disease, 2011-11, Vol.15 (11), p.1540-1546 |
| issn | 1027-3719 1815-7920 |
| language | eng |
| recordid | cdi_pascalfrancis_primary_24756119 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Adaptation, Psychological Adherence Adolescent Adult Aged Anti-HIV Agents - therapeutic use Antitubercular Agents - therapeutic use Bacterial diseases Biological and medical sciences Coinfection - drug therapy Coinfection - epidemiology Coinfection - psychology Female Health Knowledge, Attitudes, Practice HIV Infections - drug therapy HIV Infections - epidemiology HIV Infections - psychology Human bacterial diseases Human immunodeficiency virus Human viral diseases Humans Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Infectious diseases Male Medical sciences Medication Adherence - psychology Middle Aged Mycobacterium Perception Pneumology Prognosis Prospective Studies Public Opinion Regression Analysis Reproducibility of Results Respiratory system : syndromes and miscellaneous diseases Risk Assessment Risk Factors Social Stigma Stereotyping Stigma Thailand - epidemiology Tuberculosis Tuberculosis - drug therapy Tuberculosis - epidemiology Tuberculosis - psychology Tuberculosis and atypical mycobacterial infections Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Young Adult |
| title | Study of tuberculosis and AIDS stigma as barriers to tuberculosis treatment adherence using validated stigma scales |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T09%3A36%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Study%20of%20tuberculosis%20and%20AIDS%20stigma%20as%20barriers%20to%20tuberculosis%20treatment%20adherence%20using%20validated%20stigma%20scales&rft.jtitle=The%20international%20journal%20of%20tuberculosis%20and%20lung%20disease&rft.au=Kipp&rft.date=2011-11-01&rft.volume=15&rft.issue=11&rft.spage=1540&rft.epage=1546&rft.pages=1540-1546&rft.issn=1027-3719&rft.eissn=1815-7920&rft_id=info:doi/10.5588/ijtld.10.0273&rft_dat=%3Cproquest_pasca%3E911163342%3C/proquest_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=900625052&rft_id=info:pmid/22008770&rft_ingid=iuatld/ijtld/2011/00000015/00000011/art00023&rfr_iscdi=true |